Accumulation of autofluorescent storage material in brain is accelerated by ischemia in chloride channel 3 gene-deficient mice
Autofluorescent storage material (ASM) is an aging pigment that accumulates during the normal course of senescence. Although the role of ASM has yet to be fully elucidated, ASM has been implicated in age‐related neurodegeneration. In this study, we determined the level of ASM in chloride channel 3 (...
Saved in:
Published in: | Journal of neuroscience research Vol. 90; no. 11; pp. 2163 - 2172 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-11-2012
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Autofluorescent storage material (ASM) is an aging pigment that accumulates during the normal course of senescence. Although the role of ASM has yet to be fully elucidated, ASM has been implicated in age‐related neurodegeneration. In this study, we determined the level of ASM in chloride channel 3 (ClC‐3) gene‐deficient (KO) mice both in response to aging and following mild global ischemia. To understand the mechanism of action of the ASM, mice subjected to ischemia were treated with the cyclooxygenase (COX) inhibitor indomethacin or with the noncompetitive glutamate receptor antagonist MK‐801. ClC‐3 KO mice displayed age‐related neurodegeneration of the neocortex as well as the hippocampus. The cortical layers in particular granular layers became thinner with aging. ASM accumulated in the brains of ClC‐3 KO mice was increased seven‐ to 50‐fold over that observed in the corresponding regions of their wild‐type littermates. Young wild‐type mice survived longer than age‐matched ClC‐3 KO mice after permanent global ischemia. However, in the case of older animals, the survival curves were similar. The ASM also increased four‐ to fivefold 10 days after mild global ischemia, an effect that was suppressed by treatment with indomethacin and MK‐801. These results suggest that temporary ischemia might trigger a process similar to aging in the brain, mimicking the effect of age‐related neurodegenerative diseases. © 2012 Wiley Periodicals, Inc. |
---|---|
Bibliography: | ark:/67375/WNG-7T83CF3C-9 Research on Health Sciences grant focusing on Drug Innovation from The Japan Health Sciences Foundation istex:8F8C7AB77F419083A029D8D8AC7DE7E96D81D6AE ArticleID:JNR23110 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0360-4012 1097-4547 |
DOI: | 10.1002/jnr.23110 |